Maisto M, Piccolo V, Marzocchi A, Maresca D, Romano B, Summa V
Front Nutr. 2024; 11:1417747.
PMID: 39257610
PMC: 11385308.
DOI: 10.3389/fnut.2024.1417747.
Batacan Jr R, Briskey D, Bajagai Y, Smith C, Stanley D, Rao A
Biomedicines. 2024; 12(7).
PMID: 39062193
PMC: 11274356.
DOI: 10.3390/biomedicines12071620.
Rocca G, Re G
Biomolecules. 2022; 12(9).
PMID: 36139024
PMC: 9496254.
DOI: 10.3390/biom12091186.
Manzo E, Moriello A, Tinto F, Verde R, Allara M, De Petrocellis L
Cells. 2021; 10(2).
PMID: 33672574
PMC: 7924038.
DOI: 10.3390/cells10020450.
Petrosino S, Moriello A
Int J Mol Sci. 2020; 21(24).
PMID: 33333772
PMC: 7765232.
DOI: 10.3390/ijms21249526.
Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing.
Gugliandolo E, Peritore A, Piras C, Cuzzocrea S, Crupi R
Vet Sci. 2020; 7(2).
PMID: 32560159
PMC: 7355440.
DOI: 10.3390/vetsci7020078.
Noninvasive profiling of sweat-derived lipid mediators for cutaneous research.
Agrawal K, Sivamani R, Newman J
Skin Res Technol. 2018; 25(1):3-11.
PMID: 30030941
PMC: 6334639.
DOI: 10.1111/srt.12617.
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.
Petrosino S, Di Marzo V
Br J Pharmacol. 2016; 174(11):1349-1365.
PMID: 27539936
PMC: 5429331.
DOI: 10.1111/bph.13580.
Glial Modulation by N-acylethanolamides in Brain Injury and Neurodegeneration.
Herrera M, Kolliker-Frers R, Barreto G, Blanco E, Capani F
Front Aging Neurosci. 2016; 8:81.
PMID: 27199733
PMC: 4844606.
DOI: 10.3389/fnagi.2016.00081.
Lipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and Quantification.
Keereetaweep J, Chapman K
Neural Plast. 2016; 2016:2426398.
PMID: 26839710
PMC: 4709765.
DOI: 10.1155/2016/2426398.
Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis.
Abramo F, Campora L, Albanese F, Della Valle M, Cristino L, Petrosino S
BMC Vet Res. 2014; 10:21.
PMID: 24423192
PMC: 3923739.
DOI: 10.1186/1746-6148-10-21.
Epigenetic control of skin differentiation genes by phytocannabinoids.
Pucci M, Rapino C, Di Francesco A, Dainese E, DAddario C, Maccarrone M
Br J Pharmacol. 2013; 170(3):581-91.
PMID: 23869687
PMC: 3791996.
DOI: 10.1111/bph.12309.
Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for stroke.
Garg P, Duncan R, Kaja S, Zabaneh A, Chapman K, Koulen P
Neurosci Lett. 2011; 492(3):134-8.
PMID: 21296126
PMC: 3057422.
DOI: 10.1016/j.neulet.2011.01.073.
N-Myristoylated Phosphatidylethanolamine: Interfacial Behavior and Interaction with Cholesterol.
Li X, Ramakrishnan M, Brockman H, Brown R, Swamy M
Langmuir. 2010; 18(1):231-238.
PMID: 21037978
PMC: 2964846.
DOI: 10.1021/la010937t.
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.
Biro T, Toth B, Hasko G, Paus R, Pacher P
Trends Pharmacol Sci. 2009; 30(8):411-20.
PMID: 19608284
PMC: 2757311.
DOI: 10.1016/j.tips.2009.05.004.
Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor.
Dittel B
Br J Pharmacol. 2007; 153(2):271-6.
PMID: 17922025
PMC: 2219523.
DOI: 10.1038/sj.bjp.0707493.
Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines.
Okamoto Y, Morishita J, Wang J, Schmid P, Krebsbach R, Schmid H
Biochem J. 2005; 389(Pt 1):241-7.
PMID: 15760304
PMC: 1184557.
DOI: 10.1042/BJ20041790.
Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.
Franklin A, Parmentier-Batteur S, Walter L, Greenberg D, Stella N
J Neurosci. 2003; 23(21):7767-75.
PMID: 12944505
PMC: 6740602.
Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.
van der Stelt M, Hansen H, Veldhuis W, Bar P, Nicolay K, Veldink G
Neurotox Res. 2003; 5(3):183-200.
PMID: 12835123
DOI: 10.1007/BF03033139.
Anandamide and other N-acylethanolamines in human tumors.
Schmid P, Wold L, Krebsbach R, Berdyshev E, Schmid H
Lipids. 2002; 37(9):907-12.
PMID: 12458627
DOI: 10.1007/s11745-002-0978-z.